Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
The South African immigrant, who's become one of the world's richest men through his work at PayPal, Tesla and other tech companies, is a prominent Trump booster poised to play an ...